Matthieu Vallin

Matthieu Vallin is an Investor at Octopus Ventures, where he specializes in early-stage health tech startups. Since joining the firm in September 2020, he has directed capital into multiple digital health companies, currently serving as a board member for Mindstep, Ufonia, and Awell, while acting as an investor in Big Health and CoMind. He recently became a board observer at Apheris in November 2024 and has operated as a speaker and advisor for the incubator at London Business School since July 2017. Previously, Vallin worked as the Head of Health for New Ventures at Sia Partners and spent three years as a management consultant at Simon-Kucher & Partners focusing on pricing and monetization. His career combines foundational experience in engineering and strategy consulting with a current focus on scaling European entrepreneurial initiatives in the healthcare technology sector.